China’s trade figures send stocks lower

In mid-morning trading the FTSE 100 is falling fast, and the weak Chinese trade figure is weighing on commodity stocks.

Chinese flags in front of a building
Source: Bloomberg

Equity markets are lower after disappointing Chinese imports readings highlighted the economic slowdown in the country. Natural resource stocks were the worst hit by the Chinese trade figures, and as imports have declined for eleven consecutive months it paints a very clear picture that the second largest economy in the world isn’t as hungry for commodities as it once was. It is not just commodity companies that are feeling the effects of the dreadful Chinese data; European car makers and high-end fashion stocks are feeling the pinch as the middle class in China are becoming more prudent.

Bucking the trend is homebuilder Bellway, with the stock up over 3% after registering a record number of sales. These is no stopping the housebuilder as rising house prices and ultra-low interest rates are providing excellent conditions for the company to thrive in. After much ‘will they, won’t they’, it finally looks like a deal has been struck between AB InBev and SABMiller, which has pushed both stocks higher.

Sterling was sent tumbling after the UK revealed that inflation turned negative in September, and already deflation fears are playing in traders’ minds. The Bank of England will be worried that the UK could be in for a prolonged period of negative CPI, while mortgage holders can remain confident their monthly repayments won’t be rising any time soon.

In the US, we are expecting the Dow Jones to open 60 points lower at 17,060. US dealers are worried about China’s economic slowdown, and the devaluation of the yuan will hurt US exports in months to come. Investors are gearing up for the JPMorgan Chase results today, which is the first of the US banks to announce its numbers. 

Denne informasjonen er utarbeidet av IG, forretningsnavnet til IG Markets Limited. I tillegg til disclaimeren nedenfor, inneholder ikke denne siden oversikt over kurser, eller tilbud om, eller oppfordring til, en transaksjon i noe finansielt instrument. IG påtar seg intet ansvar for handlinger basert på disse kommentarene og for eventuelle konsekvenser som et resultat av dette. Ingen garanti gis for nøyaktigheten eller fullstendigheten av denne informasjonen. Personer som handler ut i fra denne informasjonen gjør det på egen risiko. Forskning gitt her tar ikke hensyn til spesifikke investeringsmål, finansiell situasjon og behov som angår den enkelte person som mottar dette. Denne informasjonen er ikke utarbeidet i samsvar med regelverket for investeringsanalyser, så derfor er denne informasjonen ansett å være markedsføringsmateriale. Selv om vi ikke er hindret i å handle i forkant av våre anbefalinger, ønsker vi ikke å dra nytte av dem før de blir levert til våre kunder. Se fullstendig disclaimer og kvartalsvis oppsummering.